@biospace Avatar @biospace BioSpace

BioSpace posts on X about $pfe, pfizer, $mrk, novo the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [------] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 59.17% finance 11.24% cryptocurrencies 2.37% countries 1.78% technology brands 1.78% vc firms 1.18% us election 0.59% travel destinations 0.59% currencies 0.59%

Social topic influence $pfe 10.65%, pfizer 8.28%, $mrk 6.51%, novo 5.92%, eli lilly #106, in the 3.55%, acquisition 2.96%, $sgen 2.96%, ceo 2.37%, $abbv #56

Top accounts mentioned or mentioned by @bitterrootbio @thermofisher @rainconsulting @pelagepharma @johnnytstine @zailab_global @ecogwendoc @kristylawrence1 @persimmonti @esedevlin @ataibeckley

Top assets mentioned Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY) Seagen Inc (SGEN) AbbVie Inc (ABBV) Incyte Corporation (INCY) Bristol-Myers Squibb Co (BMY) Sanofi (SNY) Novartis AG (NVS) Hims & Hers Health, Inc. (HIMS) Beam Therapeutics, Inc. (BEAM) Wave Life Sciences Ltd. Ordinary Shares (WVE) Stellar (XLM) SuperRare (RARE) BioMarin Pharmaceutical, Inc. (BMRN) Novo-Nordisk (NVO) Arrowhead Research Corporation (ARWR) General Electric Company (GE) Charles River Laboratories Intl. Inc (CRL) Amazon.com, Inc. (AMZN) AstraZeneca PLC (AZN) Laboratory Corp. of America Holdings (LH) RAMP (RAMP) Bio Protocol (BIO)

Top Social Posts

Top posts by engagements in the last [--] hours

"From opening new therapeutic mechanisms to repairing neuronal damage investigational molecules from Ventyx Therapeutics AC Immune Gain Therapeutics and more could shape the future of Parkinsons disease treatment. #parkinsons #pharma #biospace https://hubs.li/Q040hgLC0 https://hubs.li/Q040hgLC0"
X Link 2026-01-26T15:22Z 25.5K followers, [---] engagements

"With a clutch of key data and planned regulatory applications this year from Avidity Biosciences REGENXBIO and Capricor Therapeutics CureDuchenne CSO Michael Kelly sees momentum in the Duchenne muscular dystrophy pipeline as Sareptas Elevidys leaves the door open. #regulatory #pharma #biospace https://hubs.li/Q042gHhQ0 https://hubs.li/Q042gHhQ0"
X Link 2026-02-09T13:56Z 25.5K followers, [---] engagements

"Merck had previously offered anywhere from $28 billion to $32 billion to swallow Revolution Medicines. #pharma #biospace https://hubs.li/Q040hjDc0 https://hubs.li/Q040hjDc0"
X Link 2026-01-26T16:09Z 25.5K followers, [---] engagements

"Bristol Myers Squibb GSK and Merck are contributing drug ingredients as part of their deals with the White House but are keeping many of the terms of their agreements private. #manufacturing #bigpharma #biospace https://hubs.li/Q040tfwV0 https://hubs.li/Q040tfwV0"
X Link 2026-01-27T14:09Z 25.5K followers, [----] engagements

"The discovery of a tumor in a patient who received REGENXBIOs gene therapy for Hurler syndrome prompted the FDA to place a hold on that program along with the companys Hunter syndrome program which is awaiting an FDA decision on or before Feb. [--]. #rarediseases #genetherapy #FDA #biospace https://hubs.li/Q040JmTT0 https://twitter.com/i/web/status/2016573485611422098 https://hubs.li/Q040JmTT0 https://twitter.com/i/web/status/2016573485611422098"
X Link 2026-01-28T18:05Z 25.5K followers, [---] engagements

"In what is shaping up to be a back-loaded month the FDA is set to release a slew of regulatory decisions in February including two that would expand the labels of blockbuster drugs. #regulatory #FDA #biospace https://hubs.li/Q041fG_K0 https://hubs.li/Q041fG_K0"
X Link 2026-02-02T14:30Z 25.5K followers, [---] engagements

"AstraZenecas $15 billion pledge to its China operations highlights the countrys advantages. But other regions are also hoping to host more clinical studies. #clinicaltrials #biospace https://hubs.li/Q041fXmW0 https://hubs.li/Q041fXmW0"
X Link 2026-02-02T15:06Z 25.5K followers, [---] engagements

"As January drew to a close IO Biotech and @BitterrootBio announced workforce cuts. Learn what's behind the changes in our regularly updated layoff tracker. #layoffs #biopharma #biospace https://hubs.li/Q041gKwv0 https://hubs.li/Q041gKwv0"
X Link 2026-02-02T17:33Z 25.5K followers, [---] engagements

"Sanofi will take venglustat to regulators for Gaucher disease but an application for Fabry disease is less clear after the failure of a Phase III trial. #rarediseases #biospace https://hubs.li/Q041gLVJ0 https://hubs.li/Q041gLVJ0"
X Link 2026-02-02T18:07Z 25.5K followers, [---] engagements

"The facility which is part of Lillys $50 billion reshoring drive will make obesity drugs such as tirzepatide and retatrutide when it starts operations in [----]. #manufacturing #obesity #biospace https://hubs.li/Q041hC9F0 https://hubs.li/Q041hC9F0"
X Link 2026-02-02T19:07Z 25.5K followers, [---] engagements

"DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyos line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload. #ADC #pharma #biospace https://hubs.ly/Q041wPH_0 https://hubs.ly/Q041wPH_0"
X Link 2026-02-03T16:07Z 25.5K followers, [----] engagements

"In its [----] full year and fourth-quarter earnings call Merck executives touted the merits of recent deals and what CEO Robert Davis called probably the broadest and widest pipeline weve had in years. #pharma #biospace https://hubs.li/Q041z-NW0 https://hubs.li/Q041z-NW0"
X Link 2026-02-03T17:05Z 25.5K followers, [---] engagements

"Analysts parsed the limited data available for Pfizers obesity candidate on the pharmas fourth-quarter earnings call Tuesday looking for any nugget of additional context. #obesity #pharma #biospace https://hubs.li/Q041D0h40 https://hubs.li/Q041D0h40"
X Link 2026-02-03T18:56Z 25.5K followers, [---] engagements

"Novo Nordisk beat analyst expectations for the fourth quarter but the result was overshadowed by softened expectations for this year. #pharma #earnings #biospace https://hubs.li/Q041G0W-0 https://hubs.li/Q041G0W-0"
X Link 2026-02-03T20:45Z 25.5K followers, [---] engagements

"Pfizer announces the first data from its Metsera-acquired pipeline just ahead of its earnings call where analysts pressed execs for more details; Merck and Roche also released Q4 and full year earnings with Eli Lilly Novo Nordisk and others reporting Wednesday; REGENXBIO hits a regulatory snag ahead of its upcoming PDUFA; more. #podcast #pharma #biospace https://hubs.li/Q041MrCP0 https://hubs.li/Q041MrCP0"
X Link 2026-02-04T14:40Z 25.5K followers, [---] engagements

"Novo Nordisk CEO Maziar Mike Doustdar acknowledged the market pressure facing the companys GLP-1 products but sought to assure investors that Novo has the situation under control. #GLP1 #weightloss #wegovy #biospace https://hubs.li/Q041Nd6c0 https://hubs.li/Q041Nd6c0"
X Link 2026-02-04T19:29Z 25.5K followers, [---] engagements

"On its fourth quarter earnings call Wednesday AbbVie CEO Robert Michael called oncology and neuroscience underappreciated areas of focus for the pharma. #oncology #neuroscience #pharma #biospace https://hubs.li/Q041RT4f0 https://hubs.li/Q041RT4f0"
X Link 2026-02-04T20:07Z 25.5K followers, [---] engagements

"Novo Nordisk and Eli Lilly both think the Wegovy pill is doing well but the American rival sees the successful launch as a harbinger of good news for its own candidate orforglipron which is expected to hit the market in the second quarter. #obesity #pharma #biospace https://hubs.li/Q041RWfN0 https://hubs.li/Q041RWfN0"
X Link 2026-02-04T20:30Z 25.5K followers, [---] engagements

"In addition to claiming revenue of $19.3 billion for the fourth quarter Eli Lilly executives offered a glimpse into their strategy to expand their GLP-1 franchise into the immunology and inflammation space with trials currently underway in asthma psoriatic arthritis Crohns disease and ulcerative colitis. #GLP1 #immunology #biospace https://hubs.li/Q041Z7TJ0 https://hubs.li/Q041Z7TJ0"
X Link 2026-02-05T14:26Z 25.5K followers, [---] engagements

"One of the assets shelved by Eli Lilly is a gene therapy for dementia which it obtained in its $1.04-billion acquisition of Prevail Therapeutics in late [----]. #genetherapy #dementia #pharma #biospace https://hubs.li/Q041Z8K40 https://hubs.li/Q041Z8K40"
X Link 2026-02-05T16:11Z 25.5K followers, [---] engagements

"Novo Nordisk and Eli Lilly have been battling head-to-head in an exploding obesity market. They should never have been compared apples to apples. #editorial #obesity #biospace https://hubs.li/Q0421pDw0 https://hubs.li/Q0421pDw0"
X Link 2026-02-05T20:06Z 25.5K followers, [---] engagements

"The administrations direct-to-consumer pharmaceutical sales platform will offer products from Eli Lilly Pfizer Novo Nordisk Amgen and more at a discount though the impact of such pricing remains to be seen. #drugpricing #trumprx #biospace https://hubs.li/Q0425Dkn0 https://hubs.li/Q0425Dkn0"
X Link 2026-02-06T14:02Z 25.5K followers, [---] engagements

"Biopharmas obsession with the weight loss sectorprojected to exceed $130 billion in revenue by 2035shows no signs of slowing down as analysts gear up for a year that will test the oral market and provide key data on novel mechanisms. #biopharma #obesity #weightloss #opinion #biospace https://hubs.li/Q0425D3F0 https://hubs.li/Q0425D3F0"
X Link 2026-02-06T14:33Z 25.5K followers, [---] engagements

"Novo Nordisk has also spoken out strongly against Hims & Hers compounded Wegovy pill with CEO Maziar Mike Doustdar telling investors the knockoff version is a waste of money. #GLP1 #weightloss #biospace https://hubs.li/Q0425GFx0 https://hubs.li/Q0425GFx0"
X Link 2026-02-06T15:40Z 25.5K followers, [---] engagements

"The gene therapy uses an AAV vector to restore healthy levels of the alpha-galactosidase enzyme which is rendered dysfunctional in patients with Fabry disease leading to the toxic build-up of lipids in cells. #genetherapy #biospace https://hubs.li/Q042gQXc0 https://hubs.li/Q042gQXc0"
X Link 2026-02-09T16:02Z 25.5K followers, [---] engagements

"The deal gets Lilly access to Ornas in vivo CAR T technology. The biotechs lead asset which has yet to start clinical testing is focused on B celldriven autoimmune diseases. #pharma #biospace https://hubs.li/Q042mPhY0 https://hubs.li/Q042mPhY0"
X Link 2026-02-09T20:00Z 25.5K followers, [---] engagements

"As next-generation antibody-drug conjugates reshape cancer care digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low and ultra-low expressors match patients to the right therapies and make more precise treatment decisions. #ADC #AI #biospace https://hubs.li/Q042sr_c0 https://hubs.li/Q042sr_c0"
X Link 2026-02-10T14:36Z 25.5K followers, [---] engagements

"The agency flagged several violations at a compounding pharmacy owned by Hims & Hers including infestation by rodents birds insects and other vermin. #regulatory #FDA #pharma #biospace https://hubs.li/Q042sxsR0 https://hubs.li/Q042sxsR0"
X Link 2026-02-10T14:36Z 25.5K followers, [---] engagements

"AstraZeneca will push the pill elecoglipron into a comprehensive late-stage program that will test the drug as a monotherapy as part of a combination regimen and for several indications. #weightloss #earnings #biospace https://hubs.li/Q042sBqf0 https://hubs.li/Q042sBqf0"
X Link 2026-02-10T15:18Z 25.5K followers, [---] engagements

"Growth matters but financial stability matters most to job seekers right now. From job search priorities to hiring outlook our [----] Employment Outlook report reveals whats shaping workforce decisions. Download the full report: https://hubs.li/Q042hv-z0 https://hubs.li/Q042hv-z0"
X Link 2026-02-10T16:04Z 25.5K followers, [---] engagements

"Kailera will launch a global Phase [--] study of ribupatide this year while Hengrui will push the asset into Phase [--] in China. #obesity #GLP1 #biospace https://hubs.li/Q042syRP0 https://hubs.li/Q042syRP0"
X Link 2026-02-10T16:30Z 25.5K followers, [---] engagements

"Pfizer Eli Lilly Novartis Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI but drug discovery is not the primary success storyyet. #AI #pharma #biospace https://hubs.li/Q042FmyG0 https://hubs.li/Q042FmyG0"
X Link 2026-02-11T14:08Z 25.5K followers, [---] engagements

"A lawsuit and FDA warning ensued after Hims & Hers launched a compounded version of Novo Nordisks new obesity pill more Big Pharma report earningsincluding from weight loss rivals Novo and Eli Lillyand the gene therapy space sees another rejection. #podcast #weightloss #genetherapy #biospace https://hubs.li/Q042FysH0 https://twitter.com/i/web/status/2021605139245588672 https://hubs.li/Q042FysH0 https://twitter.com/i/web/status/2021605139245588672"
X Link 2026-02-11T15:19Z 25.5K followers, [---] engagements

"The Taiwan-based company is establishing a manufacturing center for the U.S. market. #manufacturing #pharma #biospace https://hubs.li/Q042FVFl0 https://hubs.li/Q042FVFl0"
X Link 2026-02-11T18:09Z 25.5K followers, [---] engagements

"The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application in an unusual move that sent the biotechs shares tumbling. #editorial #vaccines #FDA #biospace https://hubs.li/Q042Q_fg0 https://hubs.li/Q042Q_fg0"
X Link 2026-02-12T13:59Z 25.5K followers, [---] engagements

"Infigratinib topped even the most optimistic expectations for efficacy and safety in the late-stage PROPEL [--] study in achondroplasia Truist Securities analysts said Thursday. #rarediseases #pharma #biospace https://hubs.li/Q042Sl6m0 https://hubs.li/Q042Sl6m0"
X Link 2026-02-12T19:29Z 25.5K followers, [---] engagements

"After GSKs return of Wave Life Sciences WVE-006 as well as the mid-stage failure of Korro Bios candidate the alpha-1 antitrypsin deficiency landscape is coming into focus with Wave and Beam Therapeutics leading the way. #pharma #biospace https://hubs.li/Q041n2Zs0 https://hubs.li/Q041n2Zs0"
X Link 2026-02-02T20:03Z 25.5K followers, [---] engagements

"The FDA recommended that REGENXBIO run a new study treat more patients and include a placebo arm to support a resubmission for the gene therapy RGX-121. #FDA #genetherapy #biospace https://hubs.li/Q042sBpw0 https://hubs.li/Q042sBpw0"
X Link 2026-02-10T15:30Z 25.5K followers, [---] engagements

"Analysts are keeping a close eye on Vertexs kidney disease portfolio anchored by the IgAN drug povetacicept as its nonopioid painkiller Journavx is poised for incremental growth in the first half [----] according to BMO Capital Markets. #pharma #biospace https://hubs.li/Q042_wX00 https://hubs.li/Q042_wX00"
X Link 2026-02-13T15:23Z 25.5K followers, [---] engagements

"A Phase III readout in September [----] for rocatinlimab on which Amgen and Kyowa Kirin were collaborating in atopic dermatitis appeared underwhelming to analysts with Jefferies noting that the data came in at the lower end of efficacy and expectations. #pharma #biospace https://hubs.li/Q041g6ky0 https://hubs.li/Q041g6ky0"
X Link 2026-02-02T16:05Z 25.5K followers, [---] engagements

"Amgen believes that it can transcend the expected tradeoff between convenience and efficacy anticipating that its investigational obesity drug MariTide will continue to provide competitive weight loss even at monthly or longer schedules. #obesity #weightloss #biospace https://hubs.li/Q041N52n0 https://hubs.li/Q041N52n0"
X Link 2026-02-04T19:10Z 25.5K followers, [---] engagements

"A recurring theme Tuesday morning at Phacilitates Advanced Therapies Week was the quickly emerging potential of in vivo approaches to cell and gene therapya trend also reflected in recent investments by Eli Lilly and Regeneron. #celltherapy #genetherapy #ATW2026 #biospace https://hubs.li/Q042FW0Q0 https://hubs.li/Q042FW0Q0"
X Link 2026-02-11T14:55Z 25.5K followers, [---] engagements

"Following over a year of slow uptake Vertex Pharmaceuticals and CRISPR Therapeutics expect Casgevy revenues to nearly triple in [----] as patient access to the sickle cell disease and beta thalassemia gene therapy grows. #genetherapy #pharma #biospace https://hubs.li/Q0431CCg0 https://hubs.li/Q0431CCg0"
X Link 2026-02-13T16:33Z 25.5K followers, [---] engagements

"Ocular Therapeutixs lead asset is Axpaxli being developed for wet age-related macular degeneration. A Phase III study is underway with data expected this quarter. #pharma #biospace https://hubs.li/Q03_6LzP0 https://hubs.li/Q03_6LzP0"
X Link 2026-01-16T16:02Z 25.5K followers, [---] engagements

"Bristol Myers Squibb is partnering with Janux Therapeutics in a deal that could add up to $850 million. The partnership will allow BMS to advance a T cellbased therapy that is only activated once in the vicinity of a tumor. https://hubs.li/Q03_TFbK0 https://hubs.li/Q03_TFbK0"
X Link 2026-01-22T16:09Z 25.5K followers, [----] engagements

"With Lykos regulatory failure now squarely in the rearview mirror Compass Pathways and Definium are leading what one analyst suspects will be a very big year for psychedelics. #pschedelics #pharma #biospace https://hubs.li/Q041fDkk0 https://hubs.li/Q041fDkk0"
X Link 2026-02-02T13:59Z 25.5K followers, [---] engagements

"After review Amgen is certain that Tavneos is effective and has a favorable benefit-risk profile. The company informed the FDA on January [--] that they would not pull the drug. #rarediseases #FDA #biospace https://hubs.li/Q041MY9C0 https://hubs.li/Q041MY9C0"
X Link 2026-02-04T18:12Z 25.5K followers, [---] engagements

"After a series of deaths in patients taking Sarepta Therapeutics gene therapies doubt has crept into investor sentiments around the long-time Wall Street darling and patients may soon begin looking elsewhere. #genetherapy #pharma #biospace https://hubs.ly/Q041YF800 https://hubs.ly/Q041YF800"
X Link 2026-02-05T14:01Z 25.5K followers, [---] engagements

"Charles River Laboratories is shutting down a cell therapy site affecting [--] employees while @thermofisher is winding down operations at a production plant impacting [---] staffers. Learn more in our layoff tracker. #layoffs #biopharma #biospace https://hubs.li/Q0425Qwj0 https://hubs.li/Q0425Qwj0"
X Link 2026-02-06T16:32Z 25.5K followers, [---] engagements

"Sales of Johnson & Johnsons esketamine-based nasal spray jumped in the fourth quarter last year priming the pump for a suite of other pharmas including AbbVie champing at the bit with their own psychedelics. #psychedelics #spravato #biospace https://hubs.li/Q0426_240 https://hubs.li/Q0426_240"
X Link 2026-02-06T17:29Z 25.5K followers, [---] engagements

"Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide seeking potentially hundreds of millions in damages John Kuckelman the pharmas general counsel said. The wellness platform pulled its version of the drug just days after launching it. #GLP1 #biospace https://hubs.li/Q042gR1Q0 https://hubs.li/Q042gR1Q0"
X Link 2026-02-09T16:30Z 25.5K followers, [---] engagements

"The newly public Evommune shared data showing that EVO301 an IL-18 targeting protein cleared symptoms comparably to Regeneron and Sanofis mega-blockbuster in a mid-stage atopic dermatitis clinical trial. #immunology #pharma #biospace https://hubs.li/Q042tZMQ0 https://hubs.li/Q042tZMQ0"
X Link 2026-02-10T17:33Z 25.5K followers, [---] engagements

"Last month biopharmas let go or projected they would let go of less than [---] people combined based on BioSpace estimates down almost [----] from January [----]. Still competition for open jobs remains strong with employed and unemployed biotech and pharma professionals eyeing their next roles. #jobmarket #biopharma #biospace https://hubs.li/Q042FLzC0 https://hubs.li/Q042FLzC0"
X Link 2026-02-11T19:01Z 25.5K followers, [---] engagements

"In this episode of Denatured Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology doctors can now measure HER2 more precisely to match patients with the best treatments. #podcast #insights #ADC #biospace https://hubs.li/Q042R0kv0 https://hubs.li/Q042R0kv0"
X Link 2026-02-12T13:47Z 25.5K followers, [---] engagements

"The rare disease drugmaker is facing potential competitors for achondroplasia drug Voxzogo. Is a big M&A deal with two approved assets enough to maintain investor interest #rarediseases #investors #biospace https://hubs.li/Q042R2H00 https://hubs.li/Q042R2H00"
X Link 2026-02-12T14:29Z 25.5K followers, [---] engagements

"📊 New data: 88% of survey respondents plan to look for a new job in [----]. From job search behavior to hiring outlook and workforce sentiment within the life sciences our Employment Outlook report breaks it all down. Download the full report: https://hubs.li/Q042hypW0 https://hubs.li/Q042hypW0"
X Link 2026-02-12T15:02Z 25.5K followers, [---] engagements

"The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of injectable versions healthcare analytics firm Truveta suggests. #GLP1 #weightloss #biospace https://hubs.li/Q042R2JS0 https://hubs.li/Q042R2JS0"
X Link 2026-02-12T15:21Z 25.5K followers, [---] engagements

"The [----] Biotech Beach region of SoCal is well-known for its coastlines and warm climates but it is also home to global life sciences leaders biotech startups major pharmaceutical manufacturers and a strong network of R&D organizations. Looking for positions in the area Abbvie Eli Lilly and Mirador Therapeutics are currently hiring. Explore the map and open positions today. https://hubs.li/Q03_1n-40 https://hubs.li/Q03_1n-40"
X Link 2026-02-12T16:08Z 25.5K followers, [---] engagements

"AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a plasma-derived product. #drugpricing #biospace https://hubs.li/Q042R1tL0 https://hubs.li/Q042R1tL0"
X Link 2026-02-12T16:29Z 25.5K followers, [----] engagements

"Biopharma professionals need to understand todays job market and how they can stand out to position themselves for success. Three talent acquisition and recruiting experts discussed these topics in a BioSpace webinar from the importance of contract work to the value of an advocate. #jobmarket #biopharma #biospace https://hubs.li/Q042S6Wk0 https://hubs.li/Q042S6Wk0"
X Link 2026-02-12T17:01Z 25.5K followers, [---] engagements

"An unnamed FDA official also told reporters that it would be good for Moderna to show some humility and admit that it didnt follow the regulators recommendations in testing its mRNA flu vaccine. #regulatory #vaccines #biospace https://hubs.li/Q042SmMR0 https://hubs.li/Q042SmMR0"
X Link 2026-02-12T18:11Z 25.5K followers, [---] engagements

"The sudden departure stands in contrast to other EU pharma leaders who have been given much longer transitions in recent months including GSKs Emma Walmsley and Novo Nordisks Lars Fruergaard Jrgensen. #pharma #biospace https://hubs.li/Q042TLSK0 https://hubs.li/Q042TLSK0"
X Link 2026-02-12T19:09Z 25.5K followers, [---] engagements

"Modernas mRNA-1010 was expected to contribute $1 billion to the companys coffers by [----]. That plan is now out the window after the FDA refused to even look at the application. #vaccines #FDA #biospace https://hubs.li/Q042TLpD0 https://hubs.li/Q042TLpD0"
X Link 2026-02-12T20:06Z 25.5K followers, [---] engagements

"Vinay Prasad the FDAs Center for Biologics Evaluation and Research head is accused of interpersonal impropriety as pushback builds against his decision to reject Modernas influenza vaccine candidate. #FDA #vaccines #biospace https://hubs.li/Q042XS7p0 https://hubs.li/Q042XS7p0"
X Link 2026-02-12T21:04Z 25.5K followers, [---] engagements

"Bristol Myers Squibb delivered better than expected fourth quarter earnings but Eliquis missed expectations while Cobenfy continues to struggle with uptake. #earnings #pharma #biospace https://hubs.li/Q0421pmJ0 https://hubs.li/Q0421pmJ0"
X Link 2026-02-05T20:09Z 25.5K followers, [---] engagements

"The FDAs refusal to review Modernas mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta Capricor uniQure and many more. #FDA #mrna #vaccines #biospace https://hubs.li/Q042_yZP0 https://hubs.li/Q042_yZP0"
X Link 2026-02-13T14:12Z 25.5K followers, [---] engagements

"Ultragenyx Pharmaceutical is rolling out a strategic restructuring initiative to reduce cash burn in the process parting ways with 10% of its employees or approximately [---] people. #layoffs #pharma #biospace https://hubs.li/Q042_xJs0 https://hubs.li/Q042_xJs0"
X Link 2026-02-13T14:40Z 25.5K followers, [---] engagements

"Eli Lilly has long been gearing up for the launch of orforglipron announcing as early as February [----] that it was ramping up manufacturing investments for the weight-loss pill. #obesity #weightloss #manufacturing #biospace https://hubs.li/Q042_wX90 https://hubs.li/Q042_wX90"
X Link 2026-02-13T16:10Z 25.5K followers, [---] engagements

"Moderna will not commit to previous [----] breakeven guidance as the ripple effects of the FDAs refusal-to-file decision spread through its pipeline. #FDA #pharma #biospace https://hubs.li/Q0431JH40 https://hubs.li/Q0431JH40"
X Link 2026-02-13T17:09Z 25.5K followers, [---] engagements

"Former Biogen $BIIB Exec to Head Decibel Therapeutics http://ow.ly/IE4w302dh3g http://ow.ly/IE4w302dh3g"
X Link 2016-07-14T13:01Z 24.9K followers, [--] engagements

"Merck & Co. $MRK Plans to Open Microbiome R&D Site in Former Idenix $IDIX Facility http://ow.ly/rg1k302fvrs http://ow.ly/rg1k302fvrs"
X Link 2016-07-14T17:00Z 24.9K followers, [--] engagements

"With a Strong Cancer Presence and Pipeline Incyte $INCY Would Make a Sweet Acquisition http://ow.ly/HjZh302ieOO http://ow.ly/HjZh302ieOO"
X Link 2016-07-16T17:01Z 24.9K followers, [--] engagements

"Biogen $BIIB CEO Steps Down Amid Stellar Q2 Financials Hunt for New Leader Begins http://ow.ly/o4fH302tvNK http://ow.ly/o4fH302tvNK"
X Link 2016-07-21T16:54Z 24.9K followers, [--] engagements

"As Biogen $BIIB Boss Moves to the Bay Area California Biotechs Pay Attention http://ow.ly/75ah302vZFy http://ow.ly/75ah302vZFy"
X Link 2016-07-22T17:37Z 24.9K followers, [--] engagements

"FDA Rejects Valeant $VRX Glaucoma Drug Raises Concerns Over Manufacturing Issues http://ow.ly/qnQC302w7WH http://ow.ly/qnQC302w7WH"
X Link 2016-07-24T17:01Z 24.9K followers, [--] engagements

"Speculation Heats Up on Biogen $BIIB as an Acquisition Target or Starting a Buying Spree http://ow.ly/RW3h302ArXn http://ow.ly/RW3h302ArXn"
X Link 2016-07-25T16:59Z 24.9K followers, [--] engagements

"Abbott $ABT Sales Rep in India Blames Company in Suicide Note http://ow.ly/LBPH302AucM http://ow.ly/LBPH302AucM"
X Link 2016-07-26T13:01Z 24.9K followers, [--] engagements

"Pfizer $PFE Plans $146 Million Expansion in Michigan http://ow.ly/1A64302FkSj http://ow.ly/1A64302FkSj"
X Link 2016-07-28T01:00Z 24.9K followers, [--] engagements

"How BioMarin (BMRN)'s Model for Super-Rare Diseases Made It a $15 Billion Powerhouse http://ow.ly/Txu9302JRM1 http://ow.ly/Txu9302JRM1"
X Link 2016-07-29T17:05Z 24.9K followers, [--] engagements

"Another Round of Layoffs for Pfizer $PFE in New York http://ow.ly/der7302QV6z http://ow.ly/der7302QV6z"
X Link 2016-08-02T17:39Z 24.9K followers, [--] engagements

"Biogen $BIIB Unveils Name for New Standalone Hemophilia-Focused Company: Bioverativ http://ow.ly/sk8W3034QcK http://ow.ly/sk8W3034QcK"
X Link 2016-08-09T21:00Z 24.9K followers, [--] engagements

"Pfizer $PFE Goes Full Steam Ahead With Its Acquire-to-Expand Strategy http://ow.ly/Ih7a3039kMu http://ow.ly/Ih7a3039kMu"
X Link 2016-08-12T13:01Z 24.9K followers, [--] engagements

"Merck & Co. $MRK Slashes [---] Jobs Shuts Down Screening Plant http://ow.ly/verE303fQtG http://ow.ly/verE303fQtG"
X Link 2016-08-15T17:36Z 24.9K followers, [--] engagements

"Pfizer $PFE to Shut Down Four Hospira Distribution Centers http://ow.ly/KRJb303p2Yp http://ow.ly/KRJb303p2Yp"
X Link 2016-08-20T23:00Z 24.9K followers, [--] engagements

"Pfizer $PFE Scoops Sanofi $SNY With $14 Billion Buyout Deal for Medivation $MDVN http://ow.ly/tFH2303tosp http://ow.ly/tFH2303tosp"
X Link 2016-08-22T17:22Z 24.9K followers, [--] engagements

"Rumors Again Swirl Over BioMarin $BMRN Being a Possible Plan B for Sanofi $SNY http://ow.ly/ArFm303tph2 http://ow.ly/ArFm303tph2"
X Link 2016-08-22T21:00Z 24.9K followers, [--] engagements

"Its Official No Divorce for Pfizer $PFE's Two Units http://ow.ly/Zb9t304zZgp http://ow.ly/Zb9t304zZgp"
X Link 2016-09-26T23:00Z 24.9K followers, [--] engagements

"Novo Nordisk A/S $NVO Aims an Ax at R&D and HQ Staff Functions Will Cut Up to [----] Jobs http://ow.ly/RdTz304HpTf http://ow.ly/RdTz304HpTf"
X Link 2016-09-29T19:39Z 24.9K followers, [--] engagements

"SoCal's Arrowhead Pharma $ARWR Just Snagged a $673.5 Million Heart Deal With Amgen $AMGN http://ow.ly/nDcs304Hrnk http://ow.ly/nDcs304Hrnk"
X Link 2016-09-30T17:02Z 24.9K followers, [--] engagements

"Seattle Genetics $SGEN Adds [------] Square Feet to HQ Plans to Hire [---] New Staff Every Year http://ow.ly/ud2e304Tqlo http://ow.ly/ud2e304Tqlo"
X Link 2016-10-05T23:00Z 24.9K followers, [--] engagements

"Pfizer $PFE Retracts [--] Articles Authored by Top Cancer Researcher Who Has Since Left the Company http://ow.ly/4j323057f8N http://ow.ly/4j323057f8N"
X Link 2016-10-12T17:43Z 24.9K followers, [--] engagements

"A Look at Amgen $AMGN and Its $10 Billion Flop Onyx $AMGN http://ow.ly/oOKz305MUcY http://ow.ly/oOKz305MUcY"
X Link 2016-11-03T13:01Z 24.9K followers, [--] engagements

"Why Merck & Co. $MRK and Allergan $AGN Wont Buy Biogen $BIIB http://ow.ly/Jg9W305RSRD http://ow.ly/Jg9W305RSRD"
X Link 2016-11-06T18:00Z 24.9K followers, [--] engagements

"FDA Calls It Seattle Genetics $SGEN' Adcetris is a Breakthrough for Lymphoma http://ow.ly/o8pZ3063ToM http://ow.ly/o8pZ3063ToM"
X Link 2016-11-11T14:01Z 24.9K followers, [--] engagements

"The Murder of a Thermo Fisher Scientific $TMO Employee and the Missing Thumb Drive http://ow.ly/iGeJ306cHi0 http://ow.ly/iGeJ306cHi0"
X Link 2016-11-15T20:10Z 24.9K followers, [--] engagements

"All Eyes Will Be on Biogen $BIIB and Its Much-Anticipated Alzheimer's Data Tomorrow http://ow.ly/zaZ8306UmXv http://ow.ly/zaZ8306UmXv"
X Link 2016-12-07T18:00Z 24.9K followers, [--] engagements

"Sanofi $SNY to Cut [--] Percent of its U.S. Diabetes Workforce http://ow.ly/4oJX3073gCF http://ow.ly/4oJX3073gCF"
X Link 2016-12-12T19:30Z 24.9K followers, [--] engagements

"An Abandoned Pfizer $PFE Drug Turns People Into 'Zombies' http://ow.ly/z2WZ307go0M http://ow.ly/z2WZ307go0M"
X Link 2016-12-19T16:30Z 24.9K followers, [--] engagements

"Newly Formed Company Gains Celgene $CELG Versant Ventures Backing http://ow.ly/Lus7307gShO http://ow.ly/Lus7307gShO"
X Link 2016-12-19T18:45Z 25K followers, [--] engagements

"4 Fatal Deaths in Seattle Genetics $SGEN Early-Stage Trials of AML Drug http://ow.ly/EZp7307tFWA http://ow.ly/EZp7307tFWA"
X Link 2016-12-27T17:43Z 24.9K followers, [--] engagements

"A Turnaround: Regeneron $REGN Eyes a Comeback in [----] http://ow.ly/alew307vAIb http://ow.ly/alew307vAIb"
X Link 2016-12-29T14:01Z 24.9K followers, [--] engagements

"Listen Up Researchers: Versant Ventures to Fund [--] Dozen Biotech Startups With $400 Million http://ow.ly/w6oO307Etsv http://ow.ly/w6oO307Etsv"
X Link 2017-01-03T20:00Z 25K followers, [--] engagements

"Rumors Have Pfizer $PFE Eyeing This SoCal Biotech http://ow.ly/kv14307J0K1 http://ow.ly/kv14307J0K1"
X Link 2017-01-06T20:01Z 24.9K followers, [--] engagements

"Merck $MRK Expands Discovery to New South San Francisco Facility in Heart of Bay Area Looks to Hire [---] Employees http://ow.ly/Isls3085Liy http://ow.ly/Isls3085Liy"
X Link 2017-01-17T21:00Z 24.9K followers, [--] engagements

"485 Eli Lilly $LLY Employees Will be Out of Work Beginning March [--] http://ow.ly/kcEk308aaOL http://ow.ly/kcEk308aaOL"
X Link 2017-01-19T18:18Z 24.9K followers, [--] engagements

"On a Roll Seattle Genetics $SGEN Plans to Hire [---] in [----] http://ow.ly/hxtr308jDcD http://ow.ly/hxtr308jDcD"
X Link 2017-01-24T21:30Z 24.9K followers, [--] engagements

"Merck & Co. $MRK Opens Cambridge Exploratory Science Center Plans to Hire [--] More Employees http://ow.ly/252k308jFjw http://ow.ly/252k308jFjw"
X Link 2017-01-25T14:01Z 24.9K followers, [--] engagements

"Amgen $AMGN CEO Tells Trump the Company Plans to Hire [----] Employees This Year http://ow.ly/Ej7A308zZc9 http://ow.ly/Ej7A308zZc9"
X Link 2017-02-01T18:11Z 24.9K followers, [--] engagements

"I Am Woman Hear Me Roar: GE Corporation $GE Vows to Place [-----] Women in Technical Roles By [----] http://ow.ly/DefX308RgqE http://ow.ly/DefX308RgqE"
X Link 2017-02-10T18:01Z 24.9K followers, [--] engagements

"All Signs Have Gilead $GILD Gearing Up for a Much-Needed Acquisition http://ow.ly/sQ6W308XKnm http://ow.ly/sQ6W308XKnm"
X Link 2017-02-13T20:30Z 24.9K followers, [--] engagements

"Another Drug Bites the Dust: Merck & Co. $MRK Stops Late-Stage Alzheimers Study http://ow.ly/ppjh3092k3g http://ow.ly/ppjh3092k3g"
X Link 2017-02-15T18:08Z 24.9K followers, [--] engagements

"Bristol-Myers Squibb $BMY May Be on the Market But Pfizer $PFE Probably Won't Bite http://ow.ly/NHti3094RTI http://ow.ly/NHti3094RTI"
X Link 2017-02-16T21:30Z 24.9K followers, [--] engagements

"This Drug Could Rattle Biogen $BIIB and Be the Next Billion-Dollar Blockbuster for Celgene $CELG http://ow.ly/woF7309bjat http://ow.ly/woF7309bjat"
X Link 2017-02-20T20:35Z 24.9K followers, [--] engagements

"Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen $BIIB Alum Michael Gilman http://ow.ly/MmDe309pgfc http://ow.ly/MmDe309pgfc"
X Link 2017-02-27T21:10Z 24.9K followers, [--] engagements

"Short Sellers Load Up on Pfizer $PFE After Buyout Rumors http://ow.ly/T3kj309wRaf http://ow.ly/T3kj309wRaf"
X Link 2017-03-02T20:15Z 24.9K followers, [--] engagements

"Pfizer $PFE Eyes $100 Million Expansion New Jobs in North Carolina http://ow.ly/FIhp309Ivls http://ow.ly/FIhp309Ivls"
X Link 2017-03-08T21:00Z 24.9K followers, [--] engagements

"How [--] Laid Off Employees Turned Pfizer (PFE)'s Discarded Compounds Into Novartis AG (NVS) Gold http://ow.ly/DW29309X7Do http://ow.ly/DW29309X7Do"
X Link 2017-03-16T01:33Z 24.9K followers, [--] engagements

"Rumor Alert: Sanofi $SNY Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal http://ow.ly/78aL30acJ1y http://ow.ly/78aL30acJ1y"
X Link 2017-03-24T17:35Z 24.9K followers, [--] engagements

"Biogen $BIIB Loses Gene Therapy Pioneer to REGENXBIO http://ow.ly/veCe30alvXf http://ow.ly/veCe30alvXf"
X Link 2017-03-28T20:21Z 24.9K followers, [--] engagements

"Former Pfizer $PFE Neuroscientist to Helm New York Biotech Vencerx http://ow.ly/sJ9C30arMDj http://ow.ly/sJ9C30arMDj"
X Link 2017-04-02T17:35Z 24.9K followers, [--] engagements

"Why These [--] Drugmakers Could Buy Incyte $INCY http://ow.ly/s7Ry30aOaf3 http://ow.ly/s7Ry30aOaf3"
X Link 2017-04-13T14:05Z 24.9K followers, [--] engagements

"How Pfizer $PFE Made Most of Its $52.8 Billion Last Year http://ow.ly/Dqgc30aXFZs http://ow.ly/Dqgc30aXFZs"
X Link 2017-04-19T14:45Z 24.9K followers, [--] engagements

"Tension Rises Between Vertex $VRTX and Its Religious Investors Over Lobbying Disclosures http://ow.ly/3rOV30aZpDh http://ow.ly/3rOV30aZpDh"
X Link 2017-04-19T17:06Z 24.9K followers, [--] engagements

"Up to [----] Children Victims of Sanofi $SNY's Epilepsy Drug Says French Regulator http://ow.ly/ca1t30b1Pdh http://ow.ly/ca1t30b1Pdh"
X Link 2017-04-20T19:23Z 24.9K followers, [--] engagements

"Celgene $CELG Poaches Top R&D Cancer Exec From Merck & Co. $MRK http://ow.ly/cUfI30bksl0 http://ow.ly/cUfI30bksl0"
X Link 2017-05-01T16:46Z 24.9K followers, [--] engagements

"Why M&A Hungry Sanofi $SNY Could be Gearing Up to Buy Sarepta $SRPT http://ow.ly/QpYM30bktQB http://ow.ly/QpYM30bktQB"
X Link 2017-05-01T19:05Z 24.9K followers, [--] engagements

"Pfizer $PFE Axes [--] Drugs From Pipeline in Q1 http://ow.ly/yd4630bn7Y6 http://ow.ly/yd4630bn7Y6"
X Link 2017-05-02T19:52Z 24.9K followers, [--] engagements

"Charles River Laboratories $CRL: Business Is Booming With [---] Positions Open http://ow.ly/CPeK30btxpw http://ow.ly/CPeK30btxpw"
X Link 2017-05-07T20:20Z 24.9K followers, [--] engagements

"Thermo Fisher Scientific $TMO Bags Patheon $PTHN in $7.2 Billion Deal Pantheon Stock Soars http://ow.ly/vjj030bJWH7 http://ow.ly/vjj030bJWH7"
X Link 2017-05-15T16:45Z 24.9K followers, [--] engagements

"Amazon $AMZN Hiring to Break Into the Pharmaceuticals Business http://ow.ly/agcK30bOjWD http://ow.ly/agcK30bOjWD"
X Link 2017-05-17T17:19Z 24.9K followers, [--] engagements

"Star R&D Duo Nabs $65 Million for Iterum to Develop Shelved Pfizer $PFE Antibiotic http://ow.ly/Eitn30bSrbg http://ow.ly/Eitn30bSrbg"
X Link 2017-05-20T17:45Z 24.9K followers, [--] engagements

"26 Patients Dead After Replacing Controller for Abbott $ABT's HeartMate II Blood Pumps at Home http://ow.ly/mwTp30c0VQb http://ow.ly/mwTp30c0VQb"
X Link 2017-05-24T19:50Z 24.9K followers, [--] engagements

"Gilead $GILD Sanofi $SNY Reportedly Bidding on This $10 Billion Massachusetts Biotech http://ow.ly/Lt7I30cyLCc http://ow.ly/Lt7I30cyLCc"
X Link 2017-06-13T16:49Z 24.9K followers, [--] engagements

"Deaths Force Merck & Co. $MRK to Halt Enrollment for Blood Cancer Studies http://ow.ly/i3BM30cyMAa http://ow.ly/i3BM30cyMAa"
X Link 2017-06-13T18:05Z 24.9K followers, [--] engagements

"Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer $PFE Compounds http://ow.ly/5zKY30cyMUG http://ow.ly/5zKY30cyMUG"
X Link 2017-06-13T19:05Z 24.9K followers, [--] engagements

"Investors Relieved as Seattle Genetics $SGEN Pulls Out Win for Phase III Lymphoma Trial http://ow.ly/vgze30cU4pP http://ow.ly/vgze30cU4pP"
X Link 2017-06-26T17:27Z 24.9K followers, [--] engagements

"What Makes Biogen $BIIB and Bristol-Myers Squibb $BMY Such Attractive Takeover Targets http://ow.ly/xsIY30cWPXH http://ow.ly/xsIY30cWPXH"
X Link 2017-06-27T20:35Z 24.9K followers, [--] engagements

"Merck & Co. $MRK's Midas Touch Continues as Heart Drug Succeeds Where Others Failed http://ow.ly/4rm230cWReu http://ow.ly/4rm230cWReu"
X Link 2017-06-27T21:40Z 24.9K followers, [--] engagements

"Patient Deaths Prompt the FDA to Suspend Three of Merck & Co. $MRK's Keytruda Trials http://ow.ly/GVy930dpmiH http://ow.ly/GVy930dpmiH"
X Link 2017-07-06T17:15Z 24.9K followers, [--] engagements

"Sanofi $SNY Finally Closes a Deal Pays $750 Million for This Connecticut Biotech http://ow.ly/ltlv30dyk4c http://ow.ly/ltlv30dyk4c"
X Link 2017-07-11T21:56Z 24.9K followers, [--] engagements

"Ablynx $ABLYF Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi $SNY http://ow.ly/tzDc30dN3rc http://ow.ly/tzDc30dN3rc"
X Link 2017-07-20T19:16Z 24.9K followers, [--] engagements

"10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer http://ow.ly/IKah30dOEVo http://ow.ly/IKah30dOEVo"
X Link 2017-07-21T19:01Z 24.9K followers, [--] engagements

"2 Pharma Giants Pfizer $PFE Could Make a Megadeal on Soon http://ow.ly/oC3T30dW9lK http://ow.ly/oC3T30dW9lK"
X Link 2017-07-26T19:08Z 24.9K followers, [--] engagements

"AstraZeneca PLC $AZN Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. $MRK http://ow.ly/uBIO30dXWMr http://ow.ly/uBIO30dXWMr"
X Link 2017-07-27T21:55Z 24.9K followers, [--] engagements

"LabCorp $LH Scoops Up Giant CRO for Approximately $1.2 Billion Cash http://ow.ly/nagn30e37Ei http://ow.ly/nagn30e37Ei"
X Link 2017-07-31T16:55Z 24.9K followers, [--] engagements

"4 Clinical Projects Shelved From Pfizer $PFEs Pipeline http://ow.ly/SRJz30e7nTI http://ow.ly/SRJz30e7nTI"
X Link 2017-08-02T19:17Z 24.9K followers, [--] engagements

"Why Eli Lilly $LLY Has the Strongest Reputation in the Life Sciences Industry http://ow.ly/p4Ks30eeLOr http://ow.ly/p4Ks30eeLOr"
X Link 2017-08-08T14:30Z 24.9K followers, [--] engagements

"Regeneron $REGN Heading for Another Hiring Ramp http://ow.ly/2rZ230egjXA http://ow.ly/2rZ230egjXA"
X Link 2017-08-08T19:26Z 24.9K followers, [--] engagements

"Fired Pfizer $PFE Scientist Slated for [--] More Retractions Bringing the Total to [--] http://ow.ly/zC8Y30eN8fs http://ow.ly/zC8Y30eN8fs"
X Link 2017-08-30T19:40Z 24.9K followers, [--] engagements

"Incyte $INCY Discloses Promising New Data in Combo Drug Trial With Merck & Co. $MRK's Keytruda http://ow.ly/IYtV30eOYGe http://ow.ly/IYtV30eOYGe"
X Link 2017-08-31T20:25Z 24.9K followers, [--] engagements

"Merck & Co. $MRK Takes Out Immuno-Oncology Startup in $603 Million Deal http://ow.ly/BNLG30eYV39 http://ow.ly/BNLG30eYV39"
X Link 2017-09-07T13:52Z 24.9K followers, [--] engagements

"Eli Lilly $LLY Chops [----] Jobs Shuts Down [--] R&D Sites http://ow.ly/kDgm30eZqKu http://ow.ly/kDgm30eZqKu"
X Link 2017-09-07T18:33Z 24.9K followers, [--] engagements

"FDA Calls Regeneron $REGN Sanofi $SNY Carcinoma Drug a Breakthrough http://ow.ly/mSMS30f16Yf http://ow.ly/mSMS30f16Yf"
X Link 2017-09-08T20:20Z 24.9K followers, [--] engagements

"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist $MRK Exec http://ow.ly/xpjN30ffgn2 http://ow.ly/xpjN30ffgn2"
X Link 2017-09-18T19:05Z 24.9K followers, [--] engagements

"Bay Area's Ultragenyx $RARE Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics $DMTX http://ow.ly/3lk730ffgF8 http://ow.ly/3lk730ffgF8"
X Link 2017-09-18T20:10Z 24.9K followers, [--] engagements

"Johnson & Johnson $JNJ's Animas to Shut Down Ops and Exit Insulin Pump Biz [---] Jobs Affected http://ow.ly/sjr030fFCGc http://ow.ly/sjr030fFCGc"
X Link 2017-10-05T21:25Z 24.9K followers, [--] engagements

"Bio-Rad $BIO to Shut Down Cambridge R&D Site in Consolidation http://ow.ly/nDT730fKDaa http://ow.ly/nDT730fKDaa"
X Link 2017-10-09T17:49Z 24.9K followers, [--] engagements

"FDA Approves New Type [--] Diabetes Drug From Merck Pfizer http://ow.ly/4QwL30hnHZx http://ow.ly/4QwL30hnHZx"
X Link 2017-12-21T23:15Z 24.9K followers, [--] engagements

"4 Top-Performing S&P [---] Biotech Stocks of [----] http://ow.ly/aXnZ30htqdv http://ow.ly/aXnZ30htqdv"
X Link 2017-12-28T23:40Z 24.9K followers, [--] engagements

"Pfizer to Cut [---] Jobs as It Ends Alzheimer's Parkinson's Quest http://ow.ly/DzoI30hEyQV http://ow.ly/DzoI30hEyQV"
X Link 2018-01-08T21:30Z 24.9K followers, [--] engagements

"Novartis Steals New Oncology Head From Pfizer http://ow.ly/uJeP30hIMoH http://ow.ly/uJeP30hIMoH"
X Link 2018-01-11T19:48Z 24.9K followers, [--] engagements

"Meet the Former Pfizer Husband-and-Wife Team Who Founded Biotech TransPharm http://ow.ly/rq3t30hN21V http://ow.ly/rq3t30hN21V"
X Link 2018-01-15T21:15Z 24.9K followers, [--] engagements

"J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz http://ow.ly/yiIy30i1vhg http://ow.ly/yiIy30i1vhg"
X Link 2018-01-26T20:30Z 24.9K followers, [--] engagements

"Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech http://ow.ly/vxMV30imf13 http://ow.ly/vxMV30imf13"
X Link 2018-02-12T20:45Z 24.9K followers, [--] engagements

"Akebia Announces $85M Public Offering http://ow.ly/pVbi30j8ebS http://ow.ly/pVbi30j8ebS"
X Link 2018-03-24T02:01Z 24.9K followers, [--] engagements

"Pfizer in Talks with Procter & Gamble for Consumer Health Unit Reports Say http://ow.ly/wcGn30jivAs http://ow.ly/wcGn30jivAs"
X Link 2018-04-03T20:20Z 24.9K followers, [--] engagements

"ICER Report Suggest AbbVies Elagolix Could Strain Healthcare Budgets http://ow.ly/8MXi30jVIL6 http://ow.ly/8MXi30jVIL6"
X Link 2018-05-10T14:00Z 24.9K followers, [--] engagements

"AstraZeneca clinical trial in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) did not meet its primary endpoint http://ow.ly/xCmE30jXrpY http://ow.ly/xCmE30jXrpY"
X Link 2018-05-11T22:00Z 24.9K followers, [--] engagements

"Gilead Sciences Establishes CAR-T Manufacturing Toehold in Europe Ahead of EMA Decision http://ow.ly/dl0030k1gJi http://ow.ly/dl0030k1gJi"
X Link 2018-05-16T01:42Z 24.9K followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing